Frontiers in Pharmacology | Translational Pharmacology

Original Research

Accepted on 22 Sep 2025

Impact of the Warburg Effect on Nucleotide Homeostasis in Human Retinal Endothelial Cells and its Relevance to Proliferative Diabetic Retinopathy

in Translational Pharmacology

Andrew Gregory
Ahmed M Awad
Shaimaa Eltanani
Thangal Yumnamcha
Jenna Hart
Rao Me
Xihui Lin
Mohamed Shawky
Ahmed S Ibrahim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1660067

342 views

Mini Review

Published on 22 Sep 2025

The physiological and pharmaceutical roles of MCTs and other ingredients in intravenous emulsions containing omega-3 enriched fish oil designed to mitigate cytokine release syndrome

in Translational Pharmacology

David F. Driscoll
Bruce R. Bistrian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1673290

544 views

Review

Accepted on 19 Sep 2025

Effects of Statins on Sarcopenia with Focus on Mechanistic Insights and Future Perspectives

in Translational Pharmacology

Xianxu Zhang
Xianghong Wang
Lei Huang
Changlin Zhou
Bin Qian
Zhiqiang Luo
Yanqiang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1669591

842 views

Review

Accepted on 18 Sep 2025

Research Progress on DNA Hydroxymethylation in Atrial Fibrillation: a review

in Translational Pharmacology

Shaowei Fan
Jingjing Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591675

884 views

Review

Published on 18 Sep 2025

Retrospective evaluation of resident pharmacists’ services in a liver intensive care unit: a single-center experience

in Translational Pharmacology

Huijie Meng
Zhaoshuai Ji
Zhenyu Zhang
Yuanyuan Liu
Fang Li
Jing Tang
Guangmeng Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1583818

637 views

Review

Published on 18 Sep 2025

Multifunctional PLGA nanosystems: enabling integrated diagnostic and therapeutic strategies

in Translational Pharmacology

Yue Li
Tao Tao
Yao Xiong
Weiyu Guo
Yangbiao Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1670397

969 views

Original Research

Published on 17 Sep 2025

Clinical development prospects of siRNA drugs for tumor therapy: analysis of clinical trial registration data from 2004 to 2024

in Translational Pharmacology

Cai-E. Wang
Delong Zhen
Lukui Yang
Guifang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1637958

828 views

Original Research

Accepted on 16 Sep 2025

Comparison of Oliceridine and Sufentanil in Patient - Controlled Intravenous Analgesia for Post - thoracoscopic Nausea and Vomiting: A Prospective, Double - blind, Randomized Controlled Trial

in Translational Pharmacology

Yu Xiang Meng
sumin yuan
zijie ling
hengrui zhang
chenyang shi
yang niu
li zhang
zhibiao xu
yuyun liu
Kang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1576154

344 views

Perspective

Accepted on 16 Sep 2025

Animal-derived ingredients in medicines: A framework for ethical prescribing practices

in Translational Pharmacology

Hamdi Lababidi
Christopher Bobier
Daniel Rodger

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1693059

270 views

Original Research

Published on 16 Sep 2025

Safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of 9MW1911, an anti-ST2 monoclonal antibody: results from a first-in-human phase 1 study

in Translational Pharmacology

Qian Zhao
Qian Li
Yucan Wang
Li Li
Xue Zhao
Ni Wu
Diyi Fu
Danfeng Yin
Jing Feng
Zhitian Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1647816

1,176 views

Original Research

Accepted on 15 Sep 2025

Targeting Macrophage-Myofibroblast Transition with Caulis Spatholobi to Attenuate Renal Interstitial Fibrosis: Integrated UHPLC-Q-Exactive Orbitrap-MS, Network Pharmacology, and Experimental Validation

in Translational Pharmacology

Ziyi Song
Yunlong Zhang
Chao Yang
Kexin Ren
Yijing Cheng
Zhujiang Zhang
Tianjiao Ren
Yixuan Chen
Xue Li
Yan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1649902

270 views

Original Research

Published on 15 Sep 2025

Breaking the cancer code: a novel DNA minicircle to disable STAT3 in ovarian cancer cells SKOV3

in Translational Pharmacology

Adina-Gabriela Vasilescu
Andrei-Mihai Vasilescu
Livia Elena Sima
Natalia Baran
Ștefan-Eugen Szedlacsek

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1673427

820 views

Case Report

Accepted on 12 Sep 2025

Losartan-Associated Toothache in a Patient With Diabetes and Hypertension: A Hypothesis-Generating Case Report

in Translational Pharmacology

Li Yuan
Mingxue Tang
Shuaiju Liao
Dan Xiang
Tao Liu
Yangtian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1679182

680 views

Original Research

Published on 12 Sep 2025

Effect of structure and composition of cationic liposomes on the delivery of siRNA in vitro and in vivo

in Translational Pharmacology

Daniil V. Gladkikh
Elena V. Shmendel
Darya M. Makarova
Mikhail A. Maslov
Marina A. Zenkova
Elena L. Chernolovskaya

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1656671

1,453 views

Original Research

Published on 12 Sep 2025

A novel cytotoxic anti-B7-H3 affibody with therapeutic potential in acute myeloid leukemia

in Translational Pharmacology

Andrei-Mihai Vasilescu
Adina-Gabriela Vasilescu
Livia Elena Sima
Cristian V. A. Munteanu
Natalia Baran
Ștefan-Eugen Szedlacsek

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1684226

1,210 views

Original Research

Accepted on 11 Sep 2025

Localization of the therapeutic targets for endothelin receptor antagonists and sodium-glucose co-transporter 2 inhibitors in the chronic liver disease, primary sclerosing cholangitis

in Translational Pharmacology

Anthony Peter Davenport
Rhoda Kuc
Anna L Paterson
Thomas L Williams
William T H Gelson
Peter J Greasley
Phil Ambery
Janet J Maguire

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1680875

624 views